Homology Medicines Inc (FIXX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

ONE PATRIOTS PARK BEDFORD, MA 01730

Homology Medicines, Inc. is a clinical-stage genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology's proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its family of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.

Data as of 2021-07-19 09:46:34 -0400
Market Cap366.479 Million Shares Outstanding57.084 Million Avg 30-day Volume597.356 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.28 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.14988 52-week High/Low16.88 / 5.94 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -343.0489
Data provided by IEX Cloud
View SEC Filings from FIXX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 2 0.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 106 105 0.95% 30 (1.76%) 27 (1.57%) 11.11%
13F shares: 28.722 Million 30.099 Million -4.58% 10.124 Million 10.422 Million -2.86%
% Ownership 56.8891 66.4961 -14.45% 20.0522 23.0236 -12.91%
New Positions: 16 17 -5.88% 8 7 14.29%
Increased Positions 29 33 -12.12% 9 10 -10.0%
Closed Positions 14 17 -17.65% 5 10 -50.0%
Reduced Positions 31 33 -6.06% 6 6 0.0%
Total Calls 76.3 Thousand 38.805 Thousand 96.62% 20.5 Thousand 10 Thousand 105.0%
Total Puts 170.495 Thousand 229.549 Thousand -25.73% 36.5 Thousand 133.6 Thousand -72.68%
PUT/CALL Ratio 2.23 5.92 -62.33% 1.78 13.36 -86.68%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding FIXX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FIXX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GILLIS STEVEN

  • Director
18,000 2021-06-17 1

THISTLE MARY

  • Director
18,000 2021-06-17 1

PATTERSON MATTHEW R

  • Director
18,000 2021-06-17 1

GREGORY RICHARD J.

  • Director
18,000 2021-06-17 1

PARMAR KUSH

  • Director
18,000 2021-06-17 3

REICIN ALISE

  • Director
18,000 2021-06-17 1

POULTON JEFFREY V.

  • Director
18,000 2021-06-17 1

KELLY TIMOTHY P CHIEF OPERATING OFFICER

  • Officer
10,000 2021-04-07 7

SMITH W BRADFORD CFO & TREASURER

  • Officer
0 2021-02-05 1

TZIANABOS ARTHUR PRESIDENT & CEO

  • Officer
  • Director
0 2021-02-05 1

SEYMOUR ALBERT CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-02-05 3

COHN GABRIEL CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-05 1

5AM VENTURES IV, L.P.

5AM CO-INVESTORS IV, L.P.

5AM PARTNERS IV, LLC

DIEKMAN JOHN D

ROCKLAGE SCOTT M

SCHWAB ANDREW J.

  • 10% Owner
No longer subject to file 2020-12-22 2

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD MGMT L.P.

DEERFIELD PARTNERS, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

DEERFIELD MGMT HIF, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2020-01-29 0

RASTY SIYAMAK CHIEF OPERATING OFFICER

  • Officer
222,707 2019-07-09 0

WHEELER CAMERON

  • Director
0 2019-06-06 0

FLYNN JAMES E

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

  • Director
  • 10% Owner
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
0 2019-06-06 0

ARCH VENTURE FUND VIII, L.P.

ARCH VENTURE FUND VIII OVERAGE, L.P.

ARCH VENTURE PARTNERS VIII, L.P.

ARCH VENTURE PARTNERS VIII, LLC

BYBEE CLINTON

CRANDELL KEITH

NELSEN ROBERT

  • 10% Owner
5,768,694 2019-05-21 0

5AM VENTURES IV, L.P.

5AM PARTNERS IV, LLC

ROCKLAGE SCOTT M

DIEKMAN JOHN D

SCHWAB ANDREW J.

5AM CO-INVESTORS IV, L.P.

5AM VENTURES IV, L.P.

5AM PARTNERS IV, LLC

ROCKLAGE SCOTT M

DIEKMAN JOHN D

SCHWAB ANDREW J.

5AM CO-INVESTORS IV, L.P.

  • 10% Owner
12,301,838 2018-12-10 2

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

  • 10% Owner
No longer subject to file 2018-04-02 0

SHAH MAHENDRA

  • Director
909,742 2018-04-02 0

ROCK SPRINGS CAPITAL MANAGEMENT LP

ROCK SPRINGS CAPITAL MASTER FUND LP

ROCK SPRINGS CAPITAL LLC

  • 10% Owner
No longer subject to file 2018-04-02 0

TEMASEK HOLDINGS (PRIVATE) LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK LIFE SCIENCES PRIVATE LTD

TLS BETA PTE. LTD.

V-SCIENCES INVESTMENTS PTE LTD

  • 10% Owner
No longer subject to file 2018-04-02 0

VIDA VENTURES, LLC

VV MANAGER LLC

  • 10% Owner
No longer subject to file 2018-04-02 0

TLS BETA PTE. LTD.

TEMASEK LIFE SCIENCES PRIVATE LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK HOLDINGS (PRIVATE) LTD

  • 10% Owner
0 2018-03-28 0

FLYNN JAMES E

DEERFIELD MGMT HIF, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • Director
  • 10% Owner
  • *DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION*DIRECTOR BY DEPUTIZATION
0 2018-03-27 0

CHATTERJEE SASWATI

  • 10% Owner
475,014 2018-03-27 0

VIDA VENTURES, LLC

  • 10% Owner
0 2018-03-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

THISTLE MARY - Director

2021-06-22 17:35:44 -0400 2021-06-17 A 18,000 a 18,000 direct

GILLIS STEVEN - Director

2021-06-22 17:35:20 -0400 2021-06-17 A 18,000 a 18,000 direct

PATTERSON MATTHEW R - Director

2021-06-22 17:40:33 -0400 2021-06-17 A 18,000 a 18,000 direct

POULTON JEFFREY V. - Director

2021-06-22 17:39:50 -0400 2021-06-17 A 18,000 a 18,000 direct

PARMAR KUSH - Director

2021-06-22 17:40:48 -0400 2021-06-17 A 18,000 a 18,000 direct

GREGORY RICHARD J. - Director

2021-06-22 17:41:52 -0400 2021-06-17 A 18,000 a 18,000 direct

REICIN ALISE - Director

2021-06-22 17:40:12 -0400 2021-06-17 A 18,000 a 18,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
HOMOLOGY MEDICINES INC FIXX 2021-07-23 22:15:03 UTC -0.2583 0.3383 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 21:45:03 UTC -0.2583 0.3383 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 21:15:03 UTC -0.2583 0.3383 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 20:45:03 UTC -0.2057 0.2857 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 20:15:05 UTC -0.2057 0.2857 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 19:45:03 UTC -0.2057 0.2857 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 19:15:03 UTC -0.2057 0.2857 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 18:45:03 UTC -0.2086 0.2886 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 18:15:03 UTC -0.2086 0.2886 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 17:45:03 UTC -0.2086 0.2886 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 17:15:02 UTC -0.2086 0.2886 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 16:45:02 UTC -0.2086 0.2886 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 16:15:03 UTC -0.2086 0.2886 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 15:45:02 UTC -0.2086 0.2886 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 15:15:03 UTC -0.2086 0.2886 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 14:45:03 UTC -0.2403 0.3203 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 14:15:03 UTC -0.2403 0.3203 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 13:45:03 UTC -0.2403 0.3203 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 13:15:03 UTC -0.2403 0.3203 1300000
HOMOLOGY MEDICINES INC FIXX 2021-07-23 12:45:03 UTC -0.2403 0.3203 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund FIXX -110.0 shares, $-1709.4 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund FIXX -149.0 shares, $-2315.46 2020-03-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund FIXX -23078.0 shares, $-156238.06 2021-04-30 N-PORT
INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund FIXX -178417.0 shares, $-1207883.09 2021-04-30 N-PORT
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments FIXX -18383.0 shares, $-124452.91 2021-04-30 N-PORT

Elevate your investments